This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.

Alembic Pharmaceuticals advanced 2.35% to Rs 752.20 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug ...

Methotrexate 25mg/mL; soln for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection or ...

Vadodara: Alembic Pharmaceuticals is adding another regulated-market approval to its portfolio, reinforcing its presence in ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Methotrexate ...

Alembic Pharmaceuticals receives USFDA approval for generic Methotrexate injection, used to treat cancers and arthritis. Read more here.

TOKYO, Feb 16, 2024 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced that they have obtained ...

The New Drug Application for an additional rheumatoid arthritis (RA) indication of Methotrexate Injection has been accepted by NMPA, which is a new milestone following the China approval for psoriasis ...

Alembic Pharmaceuticals receives USFDA approval for a generic methotrexate injection used in treating cancer and arthritis.